Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

372.71
Delayed Data
As of Dec 02
 -2.85 / -0.76%
Today’s Change
325.35
Today|||52-Week Range
563.79
-31.34%
Year-to-Date
Jim Cramer's 'Mad Money' Recap: How to Handle Your Finances at Any Age
Dec 02 / TheStreet.com - Paid Partner Content
Celgene vs. Regeneron: Which Stock is a Better Pick?
Nov 29 / Zacks.com - Paid Partner Content
5 Top Performing Biotechnology Stocks of November
Dec 01 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Acorda Stops Ampyra PSWD Development, CRL for Spectrum's Qapzo...
Nov 23 / Zacks.com - Paid Partner Content
What Regeneron's CEO Thinks About Drug Pricing Under Trump
Dec 01 / TheStreet.com - Paid Partner Content
3 Biotechs That Don't Pay Dividends -- but Could
Nov 22 / MotleyFool.com - Paid Partner Content
Buy 7 Stocks with Impressive Interest Coverage Ratio
Dec 01 / Zacks.com - Paid Partner Content
Attention, Biotech Investors: Black Friday Is Already Here
Nov 21 / MotleyFool.com - Paid Partner Content
NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted...
Nov 30 / Zacks.com - Paid Partner Content
Wall Street rallies led by healthcare and banks
Nov 09 / FT.com - Paid Partner Content

Today’s Trading

Previous close375.56
Today’s open375.85
Day’s range371.32 - 378.50
Volume723,571
Average volume (3 months)831,007
Market cap$39.3B
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-3.17%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+45.55%
P/E ratio54.4
Price/Sales15.24
Price/Book10.67

Competitors

 Today’s
change
Today’s
% change
SHPGShire+3.82+2.23%
ALXNAlexion Pharmaceutic...+0.95+0.78%
ZTSZoetis Inc-0.06-0.12%
ABTAbbott Laboratories+0.30+0.80%
Data as of 4:04pm ET, 12/02/2016

Financials

Next reporting dateFebruary 14, 2017
EPS forecast (this quarter)$3.13
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts


Search for Jobs